Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.94% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PAY
651
DELISTED
Verifone Systems Inc
PAY
| $281K | ﹤0.01% |
+12,321
| New | +$273K |
|
652
Accenture
ACN
$101B
| $228K | ﹤0.01% |
1,394
-24,022
| -95% | -$3.74M |
|
653
TJX Companies
TJX
$178B
| $212K | ﹤0.01% |
+4,446
| New | +$195K |
|
654
Agilent Technologies
A
$39.7B
| – | – |
-13,447
| Closed | -$900K |
|
655
Allstate
ALL
$70.1B
| – | – |
-8,712
| Closed | -$826K |
|
656
Atara Biotherapeutics
ATRA
$70.4M
| – | – |
-7,228
| Closed | -$7.05M |
|
657
Avery Dennison
AVY
$12.9B
| – | – |
-5,288
| Closed | -$562K |
|
658
Armstrong World Industries
AWI
$7.55B
| – | – |
-10,360
| Closed | -$583K |
|
659
Biogen
BIIB
$30.4B
| – | – |
-230,771
| Closed | -$63.2M |
|
|
660
CALL
Bristol-Myers Squibb
BMY
$130B
| – | – |
-200,000
| Closed | -$12.7M |
|
661
Bruker
BRKR
$9.58B
| – | – |
-27,584
| Closed | -$825K |
|
662
Cboe Global Markets
CBOE
$31.1B
| – | – |
-10,261
| Closed | -$1.17M |
|
663
Cadence Design Systems
CDNS
$95.1B
| – | – |
-26,932
| Closed | -$990K |
|
664
Copa Holdings
CPA
$5.71B
| – | – |
-13,775
| Closed | -$1.77M |
|
665
Corbus Pharmaceuticals
CRBP
$168M
| – | – |
-6,894
| Closed | -$1.26M |
|
666
Cognizant
CTSH
$23.8B
| – | – |
-28,769
| Closed | -$2.32M |
|
667
Commault Systems
CVLT
$4.97B
| – | – |
-102,517
| Closed | -$5.86M |
|
668
Curtiss-Wright
CW
$26.9B
| – | – |
-9,355
| Closed | -$1.26M |
|
669
Evercore
EVR
$13.2B
| – | – |
-15,757
| Closed | -$1.37M |
|
670
Diamondback Energy
FANG
$53.5B
| – | – |
-5,012
| Closed | -$634K |
|
671
Fastenal
FAST
$55.2B
| – | – |
-5,569,292
| Closed | -$76M |
|
672
Federated Hermes
FHI
$4.59B
| – | – |
-19,890
| Closed | -$664K |
|
673
Fortis
FTS
$29.7B
| – | – |
-900,532
| Closed | -$30.4M |
|
674
Gilead Sciences
GILD
$167B
| – | – |
-41,255
| Closed | -$3.11M |
|
675
Corning
GLW
$108B
| – | – |
-350,917
| Closed | -$9.78M |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.95B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.